Patients With Acl Injury and Varus Knee Will Undergo Acl Reconstruction Alone, or Combined With High Tibial Osteotomy in the Same Session.
Outcomes of Anterior Cruciate Ligament Reconstruction With and Without High Tibial Osteotomy in Knees With Varus Malalignment. Comparative Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11517
- Ain shams university hospitals
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 20 and 50.
- Knee varus malalignment 7-10°.
- ACL injury with clinical anterior instability confirmed by MRI.
Exclusion Criteria:
- Osteoarthritis (Kellgren-Lawrence grade IV).
- Inflammatory joint disease.
- Knee flexion < 120°
- Knee fixed flexion deformity > 10°.
- BMI >30
- Any ligamentous or meniscal knee injury other than ACL injury.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 12 patients with varus knee malalignment and acl deficiency under went acl reconstruction and hto
anterior cruciate ligament reconstruction and medial opening wedge high tibial osteotomy in the same session
|
medial opening wedge valgus high tibial osteotomy
anterior cruciate ligament reconstruction
|
|
Active Comparator: 12 patients with varus knee malalignment and acl deficiency underwent acl reconstruction
anterior cruciate ligament reconstruction alone.
|
anterior cruciate ligament reconstruction
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lysholm knee score
Time Frame: 1 month post operative
|
knee score from 0 to 100 where a higher score means better outcome.
|
1 month post operative
|
|
Lysholm knee score
Time Frame: 3 month post operative
|
knee score from 0 to 100 where a higher score means better outcome.
|
3 month post operative
|
|
Lysholm knee score
Time Frame: 6 month post operative
|
knee score from 0 to 100 where a higher score means better outcome.
|
6 month post operative
|
|
Tegner activity level
Time Frame: 1 month post operative
|
activity level from 0 to 11 where 11 means highest level
|
1 month post operative
|
|
Tegner activity level
Time Frame: 3 months post operative
|
activity level from 0 to 11 where 11 means highest level
|
3 months post operative
|
|
Tegner activity level
Time Frame: 6 months post operative
|
activity level from 0 to 11 where 11 means highest level
|
6 months post operative
|
|
Return to pre injury level
Time Frame: through study completion, an average of 7 months
|
time needed by the patient in months post operative to return to pre injury activity level
|
through study completion, an average of 7 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
knee range of motion
Time Frame: pre operative, 1 month, 3months, and 6 months post operative
|
measure knee range of motion in degrees "flexion and extension"
|
pre operative, 1 month, 3months, and 6 months post operative
|
|
knee stability
Time Frame: pre operative, 1 month, 3months, and 6 months post operative
|
Lachman knee stability test
|
pre operative, 1 month, 3months, and 6 months post operative
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FMASU MD80/2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.